Carbapenem is an important therapy for serious hospital‐acquired infections and for the
care of patients affected by multidrug‐resistant organisms, specifically Acinetobacter …

Bacterial resistance to carbapenem agents has reached alarming levels. Accordingly,
collaborative efforts between national and international organizations and the …

Acinetobacter baumannii-calcoaceticus complex is the most commonly identified species in
the genus Acinetobacter and it accounts for a large percentage of nosocomial infections …

Pathogenic Acinetobacter species, most notably Acinetobacter baumannii, are a significant
cause of healthcare‐associated infections worldwide. Acinetobacter infections are of …

Acinetobacter baumannii is considered one of the most persistent pathogens responsible for
nosocomial infections. Due to the emergence of multidrug resistant strains, as well as high …

Acinetobacter baumannii is an opportunistic pathogen which is undoubtedly known for a
high rate of morbidity and mortality in hospital-acquired infections. A. baumannii causes life …

The use and misuse of antibiotics have made antibiotic-resistant bacteria widespread
nowadays, constituting one of the most relevant challenges for human health at present …

Multidrug-resistant Gram-negative bacteria such as Acinetobacter baumannii,
Pseudomonas aeruginosa, and members of the Enterobacterales order are a challenging …

Study objectives To investigate the clinical, epidemiologic, and microbiological
characteristics of community-acquired pneumonia (CAP) due to Acinetobacter baumannii …

Infections caused by Acinetobacter baumannii represent a major concern for intensive care
unit (ICU) patients. However, the epidemiology of these infections among COVID-19 patients …